The role of serum inflammatory factors in predicting treatment response in patients with vitiligo and concomitant Hashimoto's thyroiditis.
Dermatology Life Quality Index
Hashimoto’s thyroiditis
serum inflammatory factors
treatment
vitiligo
Journal
Postepy dermatologii i alergologii
ISSN: 1642-395X
Titre abrégé: Postepy Dermatol Alergol
Pays: Poland
ID NLM: 101168357
Informations de publication
Date de publication:
Aug 2024
Aug 2024
Historique:
received:
09
05
2024
accepted:
19
05
2024
medline:
18
9
2024
pubmed:
18
9
2024
entrez:
18
9
2024
Statut:
ppublish
Résumé
Vitiligo (VL) is associated with several autoimmune diseases, especially Hashimoto's thyroiditis, VL and concomitant Hashimoto's thyroiditis (HT) up to 34% in VL. To assess the predictive value of serum inflammatory factors in guiding treatment response among patients with concurrent VL and concomitant HT. This retrospective study enrolled 67 cases of VL and concomitant HT, and the patients according to treatment outcomes were divided into the unsatisfied group and the satisfied group. The serum thyroid parameters, autoimmune markers, and inflammatory factor levels were analysed and the correlation analysis of serum inflammatory factors was made. The study analysis of serum thyroid parameters showed elevated levels of thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), thyroperoxidase (TPO), and thyroglobulin (Tg) ( CRP, TNF-α, IL-6, IL-8, IL-10 showed the strongest correlation with VL and concomitant HT, and serum inflammatory factors levels can predict treatment response in patients with VL and concomitant HT.
Identifiants
pubmed: 39290896
doi: 10.5114/ada.2024.142287
pii: 54626
pmc: PMC11404100
doi:
Types de publication
Journal Article
Langues
eng
Pagination
372-377Informations de copyright
Copyright: © 2024 Termedia Sp. z o. o.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.